Lv11
90 积分 2024-08-09 加入
Breast cancer in China
2个月前
已完结
Restoring order at the cell cycle border: Co-targeting CDK4/6 and CDK2
3个月前
已完结
Identification of CDK2 as a novel target in treatment of prostate cancer
3个月前
已完结
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
3个月前
已完结
A review on the role of cyclin dependent kinases in cancers
3个月前
已完结
Discovery and preclinical evaluations of TQB3616, a novel CDK4-biased inhibitor
4个月前
已完结
Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2–Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2–Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial
4个月前
已完结
皖公网安备34019202002308
